Literature DB >> 24735119

MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes.

F Ferrer-Marin1, R Gutti, Z-J Liu, M Sola-Visner.   

Abstract

Entities:  

Year:  2014        PMID: 24735119      PMCID: PMC3989549          DOI: 10.1111/jth.12469

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

1.  Developmental changes in human megakaryopoiesis.

Authors:  O Bluteau; T Langlois; P Rivera-Munoz; F Favale; P Rameau; G Meurice; P Dessen; E Solary; H Raslova; T Mercher; N Debili; W Vainchenker
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

Review 2.  MicroRNAs in platelet production and activation.

Authors:  L C Edelstein; S E McKenzie; C Shaw; M A Holinstat; S P Kunapuli; P F Bray
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

3.  Gene regulation by transcription factors and microRNAs.

Authors:  Oliver Hobert
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

4.  miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.

Authors:  Juan Lu; Huanan Luo; Xiong Liu; Ying Peng; Bao Zhang; Lu Wang; Xia Xu; Xiaohong Peng; Gang Li; Wendong Tian; Ming-Liang He; Hsiangfu Kung; Xiang-Ping Li
Journal:  Carcinogenesis       Date:  2013-10-29       Impact factor: 4.944

5.  Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.

Authors:  Zhi-Jian Liu; Joseph Italiano; Francisca Ferrer-Marin; Ravi Gutti; Matthew Bailey; Brandon Poterjoy; Lisa Rimsza; Martha Sola-Visner
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

Review 6.  Determinants of platelet number and regulation of thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis.

Authors:  Catherine Labbaye; Isabella Spinello; Maria Teresa Quaranta; Elvira Pelosi; Luca Pasquini; Eleonora Petrucci; Mauro Biffoni; Eugenia Rosa Nuzzolo; Monia Billi; Robin Foà; Ercole Brunetti; Francesco Grignani; Ugo Testa; Cesare Peschle
Journal:  Nat Cell Biol       Date:  2008-06-22       Impact factor: 28.824

8.  MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.

Authors:  Kui Nie; Mario Gomez; Pablo Landgraf; Jose-Francisco Garcia; Yifang Liu; Leonard H C Tan; Amy Chadburn; Thomas Tuschl; Daniel M Knowles; Wayne Tam
Journal:  Am J Pathol       Date:  2008-07       Impact factor: 4.307

9.  Megakaryopoiesis through the ages: from the twinkle in the eye to the fully grown adult.

Authors:  C Ghevaert
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

10.  Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.

Authors:  Alexandra Mazharian; Steve P Watson; Sonia Séverin
Journal:  Exp Hematol       Date:  2009-07-18       Impact factor: 3.084

View more
  3 in total

1.  miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.

Authors:  Xiaoxiao Liu; Baofeng Yao; Zhiming Wu
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

Review 2.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

3.  MiR-9 Controls Chemotactic Activity of Cord Blood CD34⁺ Cells by Repressing CXCR4 Expression.

Authors:  Tae Won Ha; Hyun Soo Kang; Tae-Hee Kim; Ji Hyun Kwon; Hyun Kyu Kim; Aeli Ryu; Hyeji Jeon; Jaeseok Han; Hal E Broxmeyer; Yongsung Hwang; Yun Kyung Lee; Man Ryul Lee
Journal:  Int J Stem Cells       Date:  2018-11-30       Impact factor: 2.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.